EUROPEAN cannabis industry ‘pioneer’ Daniel Kruse believes that Germany is poised to ‘lead the way for a new global drug
THIS has been a transformative year for the European cannabis industry, with growing liberalisation across the continent opening the floodgates
Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over
MGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away
It is the most significant merger in the European cannabis sector. SynBiotic SE has acquired 50.1% of Daniel Kruse’s group
STENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards
CURALEAF, the US cannabis giant now valued at over $8bn, has officially completed its integration of EMMAC Life Sciences in
CHILL Brands Group, a retailer of CBD products in the US, UK and Europe, has seen some £180m wiped off
AFTER recently announcing billionaire investor Christian Angermayer had become its largest shareholder German cannabis company SynBiotic has secured a further
LOVE Hemp Group informed its investors this week that its upcoming admission to the London Stock Exchange’s (LSE) is “imminent”.
FOLLOWING its listing on the London Stock Exchange in May this year Oxford Cannabinoid Technologies (OCT) has seen more than
YOOMA Wellness Inc. (“Yooma”) (CSE: YOOM, AQSE: YOOM), a global vertically integrated wellness platform that develops and markets a portfolio
CANNABIS investors need to be wary when it comes to cultivation, says Oliver Zugel, Founder and CEO FoliuMed Holdings. Where
HELLENIC Dynamics is aiming to become the first medical cannabis cultivator to list on the London Stock Exchange. Early last
Stene Jacobs, COO of Apollon Formularies Plc, elaborates on the potential of the European cannabis industry AFTER two decades of
GERMANY’s sole domestic cannabis producer is expected to harvest its first crop in early 2022 after securing additional investment to
LEADING UK business Prohibition Holdings – parent company of global data and canna-tech firm Prohibition Partners – has acquired North
We won’t spam you
